StreetAlpha.app
Home › Stocks › NRC

Nrc Health (NRC)

$25.16
▲ +0.68%
LAST CLOSE · NOV 20

NRC Health sells subscription tools that help healthcare organizations gather and act on patient and consumer feedback. It last closed at $25.16 on Nov 20, up 0.68% on the day. The next earnings report for NRC is expected around Tue, Feb 2, 2027. For the quarter ended Sep 2026, NRC reported EPS of $0.21 on revenue of $38.4M, with revenue up 11.0% from a year ago. Over its last 8 reports the stock moved an average of 11.2% the session after earnings. Over the last 12 months NRC insiders bought $98K of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is NRC in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold NRC.

Key Stats

Last 12 months
Results
Revenue
$143.8M
+3.4% vs a year ago
Net income
$6.4M
−60.6% vs a year ago
Free cash flow
$18.4M
12.8% margin
Operating margin
11.1%
$15.9M operating income
Valuation
Market cap
$533.9M
21.2M shares
P/E
–
Price to sales
3.7
Market cap over revenue
Dividend yield
2.54%
$0.64 a share over 12 months
Balance sheet
Cash & equivalents
$3.6M
At Sep 30
Debt
$102.9M
At Sep 30
Shareholder equity
−$9.1M
Buybacks
$25.6M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $148.0M$148.0MFY2021FY2022: $151.6M$151.6MFY2022FY2023: $148.6M$148.6MFY2023FY2024: $143.1M$143.1MFY2024FY2025: $137.4M$137.4MFY2025

From NRC's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Feb 2
Estimated date · Time not announced
Reported EPS
$0.21
Quarter ended Sep 2026
Year ago EPS
$0.18
+16.7% on a GAAP basis
Revenue
$38.4M
+11.0% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.28Dec '24Mar 2025: $0.25Mar '25Jun 2025: -$0.01Jun '25Sep 2025: $0.18Sep '25Dec 2025: $49.57Dec '25Mar 2026: $0.14Mar '26Jun 2026: -$0.15Jun '26Sep 2026: $0.21Sep '26Latest $0.21
Revenue by quarter
Dec 2024: $36.9MDec '24Mar 2025: $33.6MMar '25Jun 2025: $34.0MJun '25Sep 2025: $34.6MSep '25Dec 2025: $35.2MDec '25Mar 2026: $34.8MMar '26Jun 2026: $35.4MJun '26Sep 2026: $38.4MSep '26Latest $38.4M
How NRC moved after its last 8 reports
Average move the session after a report ±11.2%
Oct 27, 2026After the close+7.9%
Jul 28, 2026After the close−18.1%
Apr 28, 2026After the close−1.8%
Feb 3, 2026Time not announced−19.5%
Oct 27, 2025After the close+16.0%
Jul 28, 2025After the close−4.8%
Apr 28, 2025After the close+9.5%
Jan 27, 2025After the close−11.8%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on NRCStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on NRC
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on NRC

Technical Analysis

NRC · as of the Nov 20 close · updated each morning
Uptrend

The stock sits between its 20 and 50 day averages. It is 22% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 55). The nearest support is the Pivot at $24.96, and the nearest resistance the 20 day average at $25.19.

Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityNormal, 4.4%/day
Key levels
$27.6052 week high+9.7%
$27.41Swing high (Nov 5)+8.9%
$25.54Pivot R1+1.5%
$25.1920 day average+0.1%
$25.16Last close
$24.96Pivot−0.8%
$24.58Pivot S1−2.3%
$22.5850 day average−10.3%
$21.90100 day average−13.0%
$21.20Swing low (Jul 10)−15.7%
$19.60200 day average−22.1%
$11.7352 week low−53.4%
Indicators
RSI (14)54.85Middle of its rangeNeutral
MACD1.03Below its signal lineBearish
Stochastic47.2Middle of its rangeNeutral
ADX (14)39.0Trending up
Williams %R-59.7Oversold below −80, overbought above −20Neutral
CCI (20)-8.9Oversold below −100, overbought above 100Neutral
Rate of change−2.7%Change over 10 sessionsBearish
ATR (14)$1.10Typical daily range, 4.4% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for NRC

What happened before

See how NRC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow NRC usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How NRC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for NRCHow many large options trades hit NRC, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

NRC Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲63 buying vs 49 selling
  • ▲Held by funds +0.8 pts
  • ▲Funds holding +3
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding128125+2.4%
In funds' top 1000–
Held by funds51.5%50.7%+0.8 pts
New / increased20 / 4317 / 44+3.3%
Reduced / sold out33 / 1639 / 11−2.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See NRC institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

NRC Insider Trading

All filings →
Insider trading · 12 months
Insiders are buying
Bought$98K1 buy · 1 insider
Sold$00 sales · 0 insiders
2026-02 bought $98KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Feb 17Shane R HarrisonEVP & CFOBuy8,000$12.27$98K
Jul 31, 2025Jordan Nicole FreemanChief Accounting OfficerBuy771$12.97$10K
May 12, 2025Patrick E Beans10% ownerBuy2,500$13.59$34K
Every insider buy and sale for NRC over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See NRC insider trades →

From SEC Form 4 filings by NRC's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NRC is in one of them and how their past NRC trades turned out.

NRC in the AI portfolios
Loading…

NRC News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NRC in an article yet. Here's the latest on the wider market.

NRC in the news

About Nrc Health

NRC Health is a healthcare experience company based in Lincoln, Nebraska. It sells subscription-based software and research tools that help healthcare organizations collect and analyze feedback from patients, consumers, clinicians and employees. Its offerings include patient experience surveys, discharge follow-up calls, brand and market research, and employee engagement tools. It also provides industry insights and networking to healthcare boards and executives.

Headquarters
Lincoln, NE
Founded
1981